293 related articles for article (PubMed ID: 21261110)
21. Multi-bed-position acquisition technique for deep inspiration breath-hold PET/CT: a preliminary result for pulmonary lesions.
Daisaki H; Shinohara H; Terauchi T; Murano T; Shimada N; Moriyama N; Tateishi U
Ann Nucl Med; 2010 Apr; 24(3):179-88. PubMed ID: 20084475
[TBL] [Abstract][Full Text] [Related]
22. Imaging of pulmonary histiocytosis X.
Kulwiec EL; Lynch DA; Aguayo SM; Schwarz MI; King TE
Radiographics; 1992 May; 12(3):515-26. PubMed ID: 1609142
[TBL] [Abstract][Full Text] [Related]
23. Abnormal fluorodeoxyglucose PET in pulmonary Langerhans cell histiocytosis.
Krajicek BJ; Ryu JH; Hartman TE; Lowe VJ; Vassallo R
Chest; 2009 Jun; 135(6):1542-1549. PubMed ID: 19447918
[TBL] [Abstract][Full Text] [Related]
24. F-18 FDG PET/CT imaging of solitary liver Langerhans cell histiocytosis: preliminary findings.
Hu X; Dong A; Lv S; Wang Q; Zhan X; Song X; Wang J
Ann Nucl Med; 2012 Jun; 26(5):436-9. PubMed ID: 22396242
[TBL] [Abstract][Full Text] [Related]
25. (18)F-FDG PET-CT respiratory gating in characterization of pulmonary lesions: approximation towards clinical indications.
García Vicente AM; Soriano Castrejón AM; Talavera Rubio MP; León Martín AA; Palomar Muñoz AM; Pilkington Woll JP; Poblete García VM
Ann Nucl Med; 2010 Apr; 24(3):207-14. PubMed ID: 20177834
[TBL] [Abstract][Full Text] [Related]
26. Idiopathic pulmonary fibrosis and diffuse parenchymal lung disease: implications from initial experience with 18F-FDG PET/CT.
Groves AM; Win T; Screaton NJ; Berovic M; Endozo R; Booth H; Kayani I; Menezes LJ; Dickson JC; Ell PJ
J Nucl Med; 2009 Apr; 50(4):538-45. PubMed ID: 19289428
[TBL] [Abstract][Full Text] [Related]
27. The value of 18F-FDG PET/CT in Langerhans cell histiocytosis.
An R; Ma X; Wang Y
Ann Nucl Med; 2024 Mar; 38(3):238-245. PubMed ID: 38217750
[TBL] [Abstract][Full Text] [Related]
28. Comparison of FDG-PET scans to conventional radiography and bone scans in management of Langerhans cell histiocytosis.
Phillips M; Allen C; Gerson P; McClain K
Pediatr Blood Cancer; 2009 Jan; 52(1):97-101. PubMed ID: 18951435
[TBL] [Abstract][Full Text] [Related]
29. Preliminary study on the evaluation of Langerhans cell histiocytosis using F-18-fluoro-deoxy-glucose PET/CT.
Zhou W; Wu H; Han Y; Wang S; Dong Y; Wang Q
Chin Med J (Engl); 2014; 127(13):2458-62. PubMed ID: 24985583
[TBL] [Abstract][Full Text] [Related]
30. Differentiation between malignancy and inflammation in pulmonary ground-glass nodules: The feasibility of integrated (18)F-FDG PET/CT.
Chun EJ; Lee HJ; Kang WJ; Kim KG; Goo JM; Park CM; Lee CH
Lung Cancer; 2009 Aug; 65(2):180-6. PubMed ID: 19155090
[TBL] [Abstract][Full Text] [Related]
31. Fluorodeoxyglucose positron emission tomography (FDG-PET) and PET/computed tomography imaging characteristics of thyroid lymphoma and their potential clinical utility.
Basu S; Li G; Bural G; Alavi A
Acta Radiol; 2009 Mar; 50(2):201-4. PubMed ID: 19089692
[TBL] [Abstract][Full Text] [Related]
32. Dual-phase 18F-FDG PET in the diagnosis of pulmonary nodules with an initial standard uptake value less than 2.5.
Chen CJ; Lee BF; Yao WJ; Cheng L; Wu PS; Chu CL; Chiu NT
AJR Am J Roentgenol; 2008 Aug; 191(2):475-9. PubMed ID: 18647920
[TBL] [Abstract][Full Text] [Related]
33. The value of liver-based standardized uptake value and other quantitative 18F-FDG PET-CT parameters in neoadjuvant therapy response in patients with locally advanced rectal cancer: correlation with histopathology.
Koç M; Kaya GÇ; Demir Y; Sürücü E; Sarioğlu S; Obuz F; Öztop İ; Görken İB; Sökmen S
Nucl Med Commun; 2015 Sep; 36(9):898-907. PubMed ID: 25969176
[TBL] [Abstract][Full Text] [Related]
34. Difficulties in the diagnosis of rare immunological diseases manifesting with cystic lung disease and spontaneous pneumothorax: Case reports.
Krawczyk P; Czekajska-Chehab E; Kieszko R; Siwiec J; Wegrzyn-Szkutnik I; Gryglicka B; Milanowski J
Heart Lung; 2004; 33(1):21-5. PubMed ID: 14983135
[TBL] [Abstract][Full Text] [Related]
35. Discrepancies between F-18-FDG PET/CT findings and conventional imaging in Langerhans cell histiocytosis.
Ferrell J; Sharp S; Kumar A; Jordan M; Picarsic J; Nelson A
Pediatr Blood Cancer; 2021 Apr; 68(4):e28891. PubMed ID: 33442960
[TBL] [Abstract][Full Text] [Related]
36. Pulmonary histiocytosis X: comparison of radiographic and CT findings.
Moore AD; Godwin JD; Müller NL; Naidich DP; Hammar SP; Buschman DL; Takasugi JE; de Carvalho CR
Radiology; 1989 Jul; 172(1):249-54. PubMed ID: 2787035
[TBL] [Abstract][Full Text] [Related]
37. Limitations of dual time point PET in the assessment of lung nodules with low FDG avidity.
Cloran FJ; Banks KP; Song WS; Kim Y; Bradley YC
Lung Cancer; 2010 Apr; 68(1):66-71. PubMed ID: 19559496
[TBL] [Abstract][Full Text] [Related]
38. Langerhans Cell Histiocytosis Showed Intense Uptake of 68 Ga-FAPI.
Pan Q; Zhang H; Cao X; Li J; Luo Y
Clin Nucl Med; 2023 Oct; 48(10):894-895. PubMed ID: 37565820
[TBL] [Abstract][Full Text] [Related]
39. Diffuse cystic lung diseases: correlation between radiologic and functional status.
Paciocco G; Uslenghi E; Bianchi A; Mazzarella G; Roviaro GC; Vecchi G; Harari S
Chest; 2004 Jan; 125(1):135-42. PubMed ID: 14718432
[TBL] [Abstract][Full Text] [Related]
40. Pulmonary Langerhans cell histiocytosis in children: a spectrum of radiologic findings.
Bano S; Chaudhary V; Narula MK; Anand R; Venkatesan B; Mandal S; Majumdar K
Eur J Radiol; 2014 Jan; 83(1):47-56. PubMed ID: 23769766
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
